Breaking News, Financial News

Financial Report: GlaxoSmithKline

Pharmaceutical sales down 6% primarily reflecting the sale of the oncology business

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

GlaxoSmithKline   2Q Revenues: £5.9 billion (+6%) 2Q Earnings: £115 million (earnings were £702 million 2Q14) YTD Revenues: £11.5 billion (+3%) YTD Earnings: £8.2 billion (earnings were £1.4 billion YTD14) Comments: Pharmaceutical sales were £3.5 billion, down 6% primarily reflecting the sale of the oncology business to Novartis. Respiratory sales declined 6%, reflecting further declines in Seretide/Advair in both the U.S. and Europe and the continuing transition of the portfolio t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters